alexa Ki 67 as Prognostic Factor in Surgically Resected Pancreatic Ductal Adenocarcinoma | OMICS International| Abstract
[Jurnalul de Chirurgie]
ISSN: 1584-9341

Journal of Surgery
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
  • Research Article   
  • Surgery 2019, Vol 15(1): 7

Ki 67 as Prognostic Factor in Surgically Resected Pancreatic Ductal Adenocarcinoma

Florina-Delia Andriesi-Rusu, Ana-Maria Trofin, Irene Cianga-Spiridon*, Nutu Vlad, Alin Vasilescu, Eugen Târcoveanu and Cristian Lupașcu
First Surgical Unit, “St. Spiridon” Hospital, University of Medicine and Pharmacy “Gr.T. Popa” Iasi, Romania
*Corresponding Author : Irene Cianga-Spiridon, MD, First Surgical Unit, “St. Spiridon” Emergency University Hospital Iasi, Independentei Street, No 1, 700544, Iasi, Romania, Tel: +40(0)741024493, Fax: +40(0)232218272, Email: [email protected]

Received Date: Apr 09, 2019 / Accepted Date: Apr 29, 2019 / Published Date: May 06, 2019


Background: Pancreatic ductal adenocarcinoma is one of the most aggressive neoplasms, with a poor prognostic and overall survival, most of the patients (over 80%) being diagnosed in advanced stages of the disease, either with distant metastasis or with the locally unresectable tumor. The Ki-67 antigen is a nuclear antigen expressed in all cellular phases (except for the G0 phase) and a high Ki-67 index can be correlated with a recurrence rate of tumor and survival.
Aim: The aim of our study was to demonstrate if the Ki-67 index can be used as a negative prognostic factor for survival.
Methods: We reviewed retrospectively all patients with pancreatic ductal adenocarcinoma (confirmed histologically) and were selected only those with resectable tumors (19.5%). For these patients, immunoreactivity for Ki-67 was evaluated according to the percentage of positive tumor nuclei. The survival was calculated from the data of surgery to a patient’s death.
Results: 19.5% of patients were diagnosed with surgically resectable tumors, with a mean tumor’s size of 3.3 cm. The overall survival rate at 2 years was 21.15%. The patients with a Ki-67 index over 80% had a significantly lower average survival than the other patients.
Conclusions: The immunohistochemistry staining for Ki-67 can be applied as a prognostic marker for survival in resectable ductal pancreatic adenocarcinoma.

Keywords: Ki-67; Pancreatic ductal adenocarcinoma; Prognostic factors; Survival

Citation: Andriesi-Rusu F, Trofin A, Cianga-Spiridon I, Vlad N, Vasilescu A, et al. Ki 67 as Prognostic Factor in Surgically Resected Pancreatic Ductal Adenocarcinoma. Journal of Surgery [Jurnalul de chirurgie]. 2019; 15(1): 01-05.

Copyright: © 2019 Andriesi-Rusu F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 288
  • [From(publication date): 0-0 - Sep 21, 2019]
  • Breakdown by view type
  • HTML page views: 256
  • PDF downloads: 32
Leave Your Message 24x7